The document discusses the use of beta-blockers (BBs) in cardiovascular practice, particularly in managing heart failure, angina, and hypertension. It highlights the importance of BBs in improving mortality rates in heart failure with reduced ejection fraction and emphasizes the necessity for careful dosage and monitoring. Additionally, it addresses common myths and cautions regarding BB administration, noting the risks of abrupt withdrawal and specific contraindications.
Related topics: